Polar Asset Management Partners Inc. Elevation Oncology, Inc. Transaction History
Polar Asset Management Partners Inc.
- $4.57 Billion
- Q1 2024
A detailed history of Polar Asset Management Partners Inc. transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 54,700 shares of ELEV stock, worth $153,160. This represents 0.01% of its overall portfolio holdings.
Number of Shares
54,700Holding current value
$153,160% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding ELEV
# of Institutions
65Shares Held
44MCall Options Held
700Put Options Held
0-
Farallon Capital Management LLC San Francisco, CA3.89MShares$10.9 Million0.09% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.37MShares$9.43 Million0.04% of portfolio
-
Tang Capital Management LLC San Diego, CA3.06MShares$8.57 Million1.91% of portfolio
-
Balyasny Asset Management LLC Chicago, IL3.06MShares$8.56 Million0.03% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$7.94 Million4.98% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $65.2M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...